Indivior Pharmaceuticals Inc
INDV
Rang în acțiuni
#4007
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Preț acțiune
$32.56
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$4.06B
Schimbare (1 zi)
-3.15%
Schimbare (1 an)
33.01%
Țară
US
Tranzacționează Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
EPS pentru Indivior Pharmaceuticals Inc (INDV)
EPS la data de June 2026 TTM: $2.84
Conform celor mai recente rapoarte financiare și prețului acțiunilor Indivior Pharmaceuticals Inc, EPS-ul actual al companiei (TTM) este $2.84. La sfârșitul anului 2023, compania avea un EPS de $0.01 o creștere față de EPS-ului din 2022, care a fost de $-0.37.
Istoricul EPS pentru Indivior Pharmaceuticals Inc din 2016 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
